frontpageheader.png
Diabetes Supply Central PDF Print E-mail

Welcome to Diabetes Supply Central, the pharmacist's resource on diabetes testing supplies. According to the American Diabetes Association, there are 23.6 million children and adults in the United States, or 7.8% of the population, who have diabetes. As the nation's most accessible health care providers, pharmacists are on the frontline assisting patients in managing this disease. That means educating patients on the importance of blood glucose monitoring and HbA1c testing, as well as providing the necessary testing supplies and demonstrating their proper use.

Diabetes Supply Central is designed to provide pharmacists with the information needed to best serve their patients with diabetes, while at the same time maintaining profitability.
 

ACCU-CHEK


Quarterly Poll

Which of the following would be considered a direct cost?
 

Diabetes News from Medical News Today


Warning: file_put_contents(/home/elinkone/public_html/accu-chek/cache/5572d7404cbd1a7cd0631787e9ccfd82.spc) [function.file-put-contents]: failed to open stream: Permission denied in /home/elinkone/public_html/accu-chek/libraries/simplepie/simplepie.php on line 7219

Warning: /home/elinkone/public_html/accu-chek/cache/5572d7404cbd1a7cd0631787e9ccfd82.spc is not writeable in /home/elinkone/public_html/accu-chek/libraries/simplepie/simplepie.php on line 1623
Latest Diabetes News From Medical News Today.
  • Is Type 2 Diabetes Mellitus A Risk Factor For Gallbladder, Biliary And Pancreatic Cancer?
    There are minimal data assessing the relationship between diabetes and gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM). A research article published on November 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team, lead by Dr.
  • Echo Therapeutics Announces Positive Results Of A Clinical Study Testing Symphony(TM) TCGM System In Patients With Type 1 And Type 2 Diabetes
    Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes.
  • American Diabetes Association Launches New Diabetes.org, Building A Community Of Help, Hope And Support
    To meet the changing needs of people affected by this growing epidemic, the American Diabetes Association has launched a completely redesigned http://www.diabetes.org in English and Spanish. Even though diabetes is a growing epidemic, a recent survey conducted by the Association showed that Americans received a failing grade in diabetes awareness.
  • Islet Cell Transplantation In Scotland
    The Scottish National Blood Transfusion Service has opened a new laboratory in Edinburgh to offer around 12 people a year islet cell transplant therapy. Islet cell transplant therapy is a pioneering treatment for diabetes that was part-funded by Diabetes UK in its research stages. About islets Islets are groups of cells in the pancreas that contain the insulin-producing beta cells.
  • Two Thirds Of Brits Do Not Know The Difference Between Type 1 And Type 2 Diabetes
    New research out today reveals that less than a third of UK residents (30 per cent) know of type 1 diabetes with a further 59 per cent confusing the autoimmune condition with type 2 diabetes - which can be related to obesity and lack of exercise. Men are the most uneducated about the condition, with only 28 per cent correctly identifying it compared with 32 per cent of women.

In Diabetes Today

The latest news and information about diabetes from the American Diabetes Association.